Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study Journal Articles Refereed uri icon

Overview

Authors

  • Authorship

    • O'BRIEN S
    • FURMAN RR
    • ILHAN O
    • KEATING MJ
    • CALL TG
    • BROWN JR
    • STEVENS-BROGAN M
    • LI Y
    • CLOW F
    • JAMES DF
    • CHU AD
    • JONES JA
    • HALLEK M
    • STILGENBAUER S
    • COUTRE SE
    • MATO AR
    • HILLMEN P
    • A/PROF Constantine Tam
    • OSTERBORG A
    • SIDDIQI T
    • THIRMAN MJ

Published in

  • Lancet Oncology

Time

Date/time value

  • 2016

Identity

Digital Object Identifier (DOI)

  • 10.1016/S1470-2045(16)30212-1

Additional Document Info

Parent Title

  • LANCET ONCOLOGY

Volume

  • 17

Issue

  • 10

Publisher

  • Lancet